These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 29793963

  • 1. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV, Blass G, Palygin O, Levchenko V, Pavlov TS, Grzybowski MN, Winsor K, Shuyskiy LS, Geurts AM, Cowley AW, Birnbaumer L, Staruschenko A.
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [Abstract] [Full Text] [Related]

  • 2. Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels.
    Ilatovskaya DV, Levchenko V, Lowing A, Shuyskiy LS, Palygin O, Staruschenko A.
    Sci Rep; 2015 Dec 10; 5():17637. PubMed ID: 26656101
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R, van der Vlag J, Baltissen MP, Verkaart SA, Wetzels JF, Berden JH, Hoenderop JG, Nijenhuis T.
    Am J Pathol; 2014 Jun 10; 184(6):1715-26. PubMed ID: 24731445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
    Ilatovskaya DV, Palygin O, Chubinskiy-Nadezhdin V, Negulyaev YA, Ma R, Birnbaumer L, Staruschenko A.
    Kidney Int; 2014 Sep 10; 86(3):506-14. PubMed ID: 24646854
    [Abstract] [Full Text] [Related]

  • 8. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV, Staruschenko A.
    Am J Physiol Renal Physiol; 2015 Sep 01; 309(5):F393-7. PubMed ID: 26084930
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes.
    Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, Shi H, Ding Y, Ma R.
    Am J Physiol Cell Physiol; 2011 Aug 01; 301(2):C304-15. PubMed ID: 21525431
    [Abstract] [Full Text] [Related]

  • 11. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
    Wang Z, Wei X, Zhang Y, Ma X, Li B, Zhang S, Du P, Zhang X, Yi F.
    Cell Physiol Biochem; 2009 Aug 01; 24(5-6):619-26. PubMed ID: 19910702
    [Abstract] [Full Text] [Related]

  • 12. Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species.
    Kim EY, Anderson M, Dryer SE.
    Am J Physiol Renal Physiol; 2012 Feb 01; 302(3):F298-307. PubMed ID: 22031853
    [Abstract] [Full Text] [Related]

  • 13. Reorganization and Suppression of Store-Operated Calcium Entry in Podocytes of Type 2 Diabetic Rats.
    Gusev K, Shalygin A, Kolesnikov D, Shuyskiy L, Makeenok S, Glushankova L, Sivak K, Yakovlev K, Orshanskaya Y, Wang G, Bakhtyukov A, Derkach K, Shpakov A, Kaznacheyeva E.
    Int J Mol Sci; 2023 Apr 14; 24(8):. PubMed ID: 37108424
    [Abstract] [Full Text] [Related]

  • 14. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
    Roshanravan H, Dryer SE.
    Am J Physiol Renal Physiol; 2014 May 01; 306(9):F1088-97. PubMed ID: 24553432
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
    Ma R, Wang Y, Xu Y, Wang R, Wang X, Yu N, Li M, Zhou Y.
    J Diabetes Res; 2021 May 01; 2021():8832114. PubMed ID: 34095318
    [Abstract] [Full Text] [Related]

  • 16. High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species.
    Liu BC, Song X, Lu XY, Li DT, Eaton DC, Shen BZ, Li XQ, Ma HP.
    Biochim Biophys Acta; 2013 Jun 01; 1833(6):1434-42. PubMed ID: 23499875
    [Abstract] [Full Text] [Related]

  • 17. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
    Li Z, Xu J, Xu P, Liu S, Yang Z.
    Cell Prolif; 2013 Feb 01; 46(1):76-85. PubMed ID: 23294354
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II induces calcium-mediated autophagy in podocytes through enhancing reactive oxygen species levels.
    Gao N, Wang H, Yin H, Yang Z.
    Chem Biol Interact; 2017 Nov 01; 277():110-118. PubMed ID: 28916337
    [Abstract] [Full Text] [Related]

  • 19. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M, Li Y, Wang L, Guo B, Mei W, Zhu B, Zhang J, Ding Y, Meng B, Zhang L, Xiang L, Dong J, Liu M, Xiang L, Xiang G.
    Diabetologia; 2020 Sep 01; 63(9):1916-1931. PubMed ID: 32588068
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, Möller CC, Hamming I, Navis G, Wetzels JF, Berden JH, Reiser J, Faul C, van der Vlag J.
    Am J Pathol; 2011 Oct 01; 179(4):1719-32. PubMed ID: 21839714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.